bearish
Impact of SK Biopharm Lock-Up Expirations
319 Views03 Aug 2020 14:57
In this insight, we provide an analysis of the upcoming lock-up expirations of SK Biopharmaceuticals (326030 KS), which are likely to put continued...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Trading Strategy for Kakao Games Post IPO Pricing31 Aug 2020
- Kakao Games IPO Bookbuilding: Mood, Book Pricing, & Exit Price Level26 Aug 2020
- Kakao Games - Concerns About Employees Leaving Post IPO13 Aug 2020
- SK Biopharm - Clear Signs of Overshooting07 Jul 2020
- SK Biopharm Valuation Analysis (What Is the Market Implying from SK Holdings?)15 Jun 2020
- SK Biopharm IPO Preview19 May 2020
x